Arsani William, Director at Design Therapeutics, Inc. (DSGN), bought 1,917,627 shares at $20.00 ($14.0M) on 2021-03-30, disclosed to the SEC on 2021-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,217,627 | $0 | 0.0% |
| 2 | $20.00 | 700,000 | $14.0M | 100.0% |
| Total | $7.30 avg | 1,917,627 | $14.0M | 100% |
| Filing → |
| DSGN | BUY | 2023-08-30 | $5.4M | — | Filing → |
| DSGN | BUY | 2022-03-22 | $950K | — | Filing → |
| DSGN | BUY | 2021-09-02 | $618K | — | Filing → |